|

NZD/USD looks to extend 6-day winning run despite China's inflation struggles

  • NZD/USD stays mildly bid even as China data shows persistent factory deflation. 
  • China's economic rebound may not be as strong as expected, the weak PPI suggests
  • Coronavirus vaccine hopes bode well for risk assets, including the NZD.

NZD/USD trades well above 0.68 at press time and looks to extend its six-day winning run despite the dismal China inflation. 

The Producer Price Inflation or factory-gate prices fell by 2.1% year-on-year in October versus an expected drop of 2%, while the Consumer Price Index declined by 0.3% month-no-month, missing the expectation for a 0.2% rise and bringing the annualized growth to 0.5% from September's 0.8%. 

The persistent factory deflation highlights a weakness in industrial demand and suggests that China's economic recovery may not be as strong as previously anticipated. The data is bearish for commodity dollars like the NZD. So far, however, the Kiwi bears have remained on the sidelines, allowing the pair to keep marginal gains above 0.6820. 

The NZD's resilience could be associated with New Zealand's relative success in stamping out coronavirus and the pro-risk environment in the financial markets. The US drug giant Pfizer announced positive results of its coronavirus vaccine on Monday, triggering a rally in the US stocks and a sharp sell-off in gold, a haven asset. 

The NZD/USD pair rose over 0.73% on Monday to register its sixth straight day of gains. 

Technical levels

NZD/USD

Overview
Today last price0.6823
Today Daily Change-0.0002
Today Daily Change %-0.03
Today daily open0.6825
 
Trends
Daily SMA200.6668
Daily SMA500.6659
Daily SMA1000.6618
Daily SMA2000.6398
 
Levels
Previous Daily High0.6856
Previous Daily Low0.6783
Previous Weekly High0.6803
Previous Weekly Low0.6589
Previous Monthly High0.6726
Previous Monthly Low0.6546
Daily Fibonacci 38.2%0.6828
Daily Fibonacci 61.8%0.6811
Daily Pivot Point S10.6786
Daily Pivot Point S20.6748
Daily Pivot Point S30.6714
Daily Pivot Point R10.6859
Daily Pivot Point R20.6894
Daily Pivot Point R30.6932

Author

Omkar Godbole

Omkar Godbole

FXStreet Contributor

Omkar Godbole, editor and analyst, joined FXStreet after four years as a research analyst at several Indian brokerage companies.

More from Omkar Godbole
Share:

Editor's Picks

EUR/USD retakes 1.1800 on renewed USD weakness

EUR/USD gains ground after three days of losses, re-attempting 1.1800in the European trading hours on Thursday. The US Dollar sees fresh selling interest across the board, despite hawkish Fed Minutes, as the market mood improves and supports the pair. US Jobless Claims data, Fedspeak and geopolitics remain in focus. 

GBP/USD recovers above 1.3500 amid better mood

GBP/USD finds fresh demand and rises back above 1.3500 in the European session on Thursday. Improving risk sentiment and renewed US Dollar weakness are helping the pair recover ground ahead of mid-tier US data releases and Fedspeak. 

Gold clings to gains above $5,000 amid safe-haven flows and Fed rate cut bets

Gold sticks to modest intraday gains, above the $5,000 psychological mark, through the first half of the European session, though it lacks bullish conviction amid mixed cues. The third round of US-mediated negotiations between Ukraine and Russia concluded in Geneva on Wednesday without any major breakthrough.

Injective token surges over 13% following the approval of the mainnet upgrade proposal

Injective price rallies over 13% on Thursday after the network confirmed the approval of its IIP-619 proposal. The green light for the mainnet upgrade has boosted traders’ sentiment, as the upgrade aims to scale Injective’s real-time Ethereum Virtual Machine architecture and enhance its capabilities to support next-generation payments. The technical outlook suggests further gains if INJ breaks above key resistance.

Hawkish Fed minutes and a market finding its footing

It was green across the board for US Stock market indexes at the close on Wednesday, with most S&P 500 names ending higher, adding 38 points (0.6%) to 6,881 overall. At the GICS sector level, energy led gains, followed by technology and consumer discretionary, while utilities and real estate posted the largest losses.

Injective token surges over 13% following the approval of the mainnet upgrade proposal

Injective price rallies over 13% on Thursday after the network confirmed the approval of its IIP-619 proposal. The green light for the mainnet upgrade has boosted traders’ sentiment, as the upgrade aims to scale Injective’s real-time Ethereum Virtual Machine architecture and enhance its capabilities to support next-generation payments.